Have a research question to share or an article to highlight?
A piece to write about neuroscience, eye tracking or neuroClues?
Let’s connect.
An article written by our co-founders Antoine Pouppez and Pierre Pouget, and published on ADN: NeuroClues, a start-up developing a medical device based on eye-tracking,
The newsletter of this month will emphasize the latest research about Spinocerebellar Ataxia
The newsletter of this month will emphasize the latest research about Parkinson’s disease (PD) as April is Parkinson’s Awareness month
The newsletter of this month is related to the relevance of eye tracking in Alzheimer’s disease
In summary P3Lab is one of the 78 companies selected among 1092 applicants by the European program EIC Accelerator. The funds will enable the company
The newsletter of this month is related to the relevance of eye tracking in Concussion
The newsletter of this month is related to the relevance of eye tracking in Deep Brain Stimulation (DBS) for Parkinson’s disease (PD).
The newsletter of this month is related to the analysis of eye movements for differential diagnosis of Multiple System Atrophy.
P3Lab receives ISO 13485:2016 certification for design and development of eye tracking devices
The newsletter of this month is related to the analysis of eye movements for the early diagnosis, differential diagnosis and follow-up of Parkinson’s disease.
neuroClues is powered by P3Lab SRL
VAT: BE 0750.746.841
Centre Monnet – Av. Jean Monnet, 1 – 1348 Louvain-la-Neuve – Belgium
iPeps Incubator – 187 rue Chevaleret – 75013 Paris – France
Our development is financed with the support of the Walloon Region and the European Innovation Council
neuroClues is powered by P3Lab SRL
VAT: BE 0750.746.841
Centre Monnet – Av. Jean Monnet, 1 –
1348 Louvain-la-Neuve – Belgium
iPeps Incubator – 187 rue Chevaleret – 75013 Paris – France
Our development is financed with
the support of the Walloon Region and the European Innovation Council
© Neuroclues 2022 – all rights reserved
Book a custom virtual walk-through of NeuroClues with one of our experts and see how our innovative eye-tracking technology could impact your clinical practice.